Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | MMP9 | P14780 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 15/20 | 0.64 |
| ▸ | CA2 | P00918 | 15/20 | 0.64 |
| ▸ | CA9 | Q16790 | 13/20 | 0.64 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA6 | P23280 | 3/20 | 0.64 |
| ▸ | CA5A | P35218 | 3/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11748392 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL5605250 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| Methanesulfonic Acid Dodecyl Ester SCHEMBL2223590 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL7726676 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL1899016 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL11225069 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL1443722 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL3092383 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL140845 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA | |
| SCHEMBL11236129 | 1.00 | TSHR (0.75) | TSHRKDM4EUSP2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9707292-B2 | Lipids and compositions for the delivery of therapeutics | ARBUTUS BIOPHARMA CORPORATION (CA) | 2017-07-18 | — | — | US | disclosed |
| US-20160199485-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | TEKMIRA PHARMACEUTICALS CORPORATION (CA) | 2016-07-14 | — | — | US | disclosed |
| US-9145432-B2 | Compounds useful in various fields of a lubricant | FUJIFILM CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20140012028-A1 | COMPOUND | FUJIFILM CORPORATION (JP) | 2014-01-09 | — | — | US | disclosed |
| US-8552213-B2 | Compound | FUJIFILM CORPORATION (JP) | 2013-10-08 | — | — | US | disclosed |
| US-8524644-B2 | Composition and method for forming coating film | FUJIFILM CORPORATION (JP) | 2013-09-03 | — | — | US | disclosed |
| CN-102548985-A | Substituted carbonyl compounds | UBE INDUSTRIES | 2012-07-04 | — | — | CN | disclosed |
| CN-102317420-A | Composition and method for forming coating film | FUJIFILM CORP | 2012-01-11 | — | — | CN | disclosed |
| CN-102046583-A | Compound | FUJIFILM CORP | 2011-05-04 | — | — | CN | disclosed |
| US-20110034357-A1 | COMPOSITION AND METHOD FOR FORMING COATING FILM | FUJIFILM CORPORATION (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110015422-A1 | COMPOUND | FUJIJILM CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2272820-A1 | COMPOUND | FUJIFILM Corporation (JP) | 2011-01-12 | — | — | EP | disclosed |
| EP-2267106-A1 | COMPOSITION AND METHOD FOR FORMING COATING FILM | FUJIFILM Corporation (JP) | 2010-12-29 | — | — | EP | disclosed |
| EP-0146258-A2 | Glycerol derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1985-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012028-A1 | COMPOUND | ALK, CCNL2, ACSL3 | TSHR 2180/4885KDM4E 2639/4885USP2 2552/4885 |
| US-20160199485-A1 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | PHOSPHO1, MBOAT1, SGMS1 | TSHR 892/4885KDM4E 2104/4885USP2 2849/4885 |
| US-20110015422-A1 | COMPOUND | ALK, DEGS1, CACNA1A | TSHR 2374/4885KDM4E 2203/4885USP2 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.